Dynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.80), versus ($0.94) reported last year. Revenue for the quarter came in at $1.55 million, versus $3.05 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.